Canada
Bennett Jones LLP
Water management a high priority—Alberta's largest water-sharing effort ever is underway Drone use and data driving decision making
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Fasken
The federal Parliament tabled Bill C-64, An Act respecting pharmacare (the "Bill"), on February 29, 2024. The Bill outlines the first phase of the federal government's...
Fasken (French)
Le 26 janvier, Santé Canada a publié un avis précisant comment l'état « dormant » d'un médicament dans la base de données sur les produits pharmaceutiques...
McCarthy Tétrault LLP
Earlier this month, the NDP and the Liberals announced a deal to introduce the first piece of a national pharmacare program providing federal funding for medications for Canadians.
Gardiner Roberts LLP
An investigative report published yesterday on CBC.ca reveals that former Shoppers Drug Mart (SDM) employees are alleging that intense pressure from SDM...
Torys LLP
Agriculture has historically been among Canada's most important economic drivers. However, it is marked by unique challenges including changing environmental conditions...
Torys LLP
Cellular agriculture is considered a pioneering technology, which presents not only opportunities for resource security but a variety of uses beyond the food chain.
Torys LLP
Cellular agriculture is heralded as enabling food security and bringing more innovative products to consumers; however, there are still barriers to its adoption. What changes need to happen...
Smart & Biggar
We previously reported Health Canada's March 27, 2023 consultation on its proposed application of the definition of Canadian reference product (CRP) based on "Dormant Status" under s. C.08.001.1(b)...
Gowling WLG
On May 12, 2023, Health Canada published a cost recovery proposal for natural health products (NHPs). The dietary supplement industry's response has been overwhelmingly critical of the proposal for a variety of reasons.
Gowling WLG
A geographical indication (or "GI") is a type of intellectual property protected by the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)...
Smart & Biggar
On May 26, 2023, the Minister of Health determined that Biosimilar Collaborations Ireland Limited was entitled to the benefit of section 5 of the Patented Medicines (Notice of Compliance) Regulations (Regulations)...
Smart & Biggar
In a decision dated January 24, 2024, Justice Pallotta allowed Novartis' application, finding that Biogen and Samsung's use of the trademark BYOOVIZ in association with an ophthalmologic drug...
Lenczner Slaght LLP
If your 2024 has been too busy to keep up with caselaw, below we summarize and provide the key takeaways from pharmaceutical patent decisions...
Osler, Hoskin & Harcourt LLP
The federal government's recently introduced Bill C-61 supports both a First Nations drinking water class action settlement agreement and further efforts to incorporate...
Aird & Berlis LLP
For many Canadians, pharmaceutical names are an alphabet soup. Biogen's BYOOVIZ and Novartis's BEOVU trademarks are classic examples of drug brand names comprised of coined words.
Fillmore Riley
Made in Canada and Product of Canada claims can set your product apart. Knowing the rules around their use and how to obtain them could provide the marketing and advertising edge your business needs.
Smart & Biggar
On December 23, 2023, the Federal Court of Appeal (FCA) held that it was an abuse of process for Apotex to raise invalidity in defending actions under the Patented Medicines...
MLT Aikins LLP
The Legal Harvest: this is the first blog in a series that covers the latest developments in agriculture and food-related law, including litigation, legislation and regulations.